Deciphera Pharmaceuticals, Inc.

The European Medicines Agency has begun reviewing a new batch of products for potential pan-EU marketing approval, including vimseltinib and a recombinant pertussis vaccine (RPV), both of which could

After a strong start to biopharma merger-and-acquisition activity in the first quarter of 2024, transactions declined notably in the second quarter, according to data provided by Evaluate. The second

The cash keeps coming into SynOx Therapeutics Ltd. , with the Ireland-domiciled biotech securing over $100m in the past week to push its late-stage asset emactuzumab over the regulatory finishing lin

Ono Pharmaceutical Company, Ltd. , a Japanese pharmaceutical firm, has ambitions to become a global specialty pharma company and has made a move to strengthen its geographic footprint. The company ann